Skip to content

Deep Neuromuscular Blockade in Strabismus Surgery

The Effect of the Deep Neuromuscular Block on the Refraction and the Oculocardiac Reflex During Strabismus Surgery in Pediatric Patients - a Prospective Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05882643
Enrollment
201
Registered
2023-05-31
Start date
2024-10-02
Completion date
2025-11-26
Last updated
2026-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Strabismus

Brief summary

The purpose of this study is to determine if inducing a moderate or greater neuromuscular block (TOF count 0-3) when performing a neuromuscular block in pediatric patients aged 3 to 18 years undergoing strabismus surgery under general anesthesia can reduce the incidence of the oculocardiac reflex.

Interventions

OTHERmoderate to deep neuromuscular blockade

* Maintaining moderate to deep neuromuscular blockade during an intraoperative period (Train-of-four 0-3 count, post-tetanic count \> 1) * Rocuronium (intravenous, 1.0 mg/kg at induction period)

OTHERshallow to minimal neuromuscular blockade

* Maintaining shallow to minimal neuromuscular blockade during an intraoperative period (Train-of-four 4, post-tetanic count \< 0.9) * Rocuronium (intravenous, 0.3 mg/kg at induction period)

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
3 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Pediatric patients between the ages of 3 and 18 who are American Society of Anesthesiologists physical classification (ASA) I, II, or III scheduled for strabismus surgery under general anesthesia.

Exclusion criteria

* Patients with underlying cardiovascular disease * Patients with preoperative electrocardiograms showing conduction disturbances * Patients with neuromuscular disease * Any other patient who, in the opinion of the investigator, is not a good candidate for the study.

Design outcomes

Primary

MeasureTime frameDescription
The incidence of grade 2 or greater oculocardiac reflex (during strabismus surgery)Day 1, During general anesthesia for strabismus surgery (within 2 hours).\> 20% reduction in heart rate during strabismus surgery

Secondary

MeasureTime frameDescription
The incidence of grade 1 oculocardiac reflex (during strabismus surgery)Day 1, During general anesthesia for strabismus surgery (within 2 hours).\< 20% reduction in heart rate during general anesthesia for strabismus surgery (within 2 hours).
The incidence of grade 3 or greater oculocardiac reflex (during strabismus surgery)During general anesthesia for strabismus surgery (usually within 2 hour)\> 30% decrease in heart rate (moderate oculocardiac reflex) during strabismus surgery
The incidence of hypotensionDuring general anesthesia for strabismus surgery (within 2 hour)The incidence of hypotension, defined as a drop to 20% or more of baseline mean blood pressure
Postoperative nausea/vomitingFrom extubation to post-anesthesia care unit stay (within 1 hour)Presence of postoperative nausea/vomiting as assessed in the recovery room
Results from a refraction test before strabismus surgeryBefore strabismus surgery (within 12 month)Results from a refraction test before strabismus surgery measured at outpatient clinic
Results from a refraction test at strabismus surgeryDuring general anesthesia for strabismus surgery (within 2 hour)Results from a refraction test during strabismus surgery

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 24, 2026